CLVRX Mutual Fund

NAV$42.88

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
0.19%
Dividend Yield (Current)
7.69%
Holdings
548
Inception Date
Feb 1, 2022
Fund Family
Calvert
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+19.09%
1 Year+31.90%
3 Year+20.11%

Asset Allocation

Stocks: 99.83%
Cash: 0.17%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
JPM:USJp Morgan Chase & Co3.46%
BAC.KBank Of America Corp2.02%
MRKMerck & Co. Inc.1.74%
WFCWells Fargo & Co1.47%
UNHUnitedhealth Group, Inc.1.46%
Top 10 Concentration: 16.66%Report Date: Mar 31, 2026
Download all 548 holdings for CLVRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
7.69%
Frequency
Annually

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how CLVRX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

CLVRX Mutual Fund Overview

CLVRX Mutual Fund (Calvert US Large Cap Value Responsible Index Fund Class R6) is managed by Calvert. CLVRX expense ratio is 0.19%, holding 548 positions across sectors including Financials, Health Care, Unknown. Inception date: 2022-02-01.

CLVRX performance shows a YTD return of 19.09%. The 1-year return is 31.90%. CLVRX dividend yield stands at 7.69%, paid annually.

CLVRX top holdings include Jp Morgan Chase & Co (3.5%), Bank Of America Corp (2.0%), Merck & Co. Inc. (1.7%), Wells Fargo & Co (1.5%), Unitedhealth Group, Inc. (1.5%). View all CLVRX holdings, sector breakdown, or dividend history.

CLVRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. CLVRX alternatives are available via the screener, along with tax-loss harvesting opportunities.